We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IBXXD market cap is 31.34M. The company's latest EPS is AUD -0.4002 and P/E is -0.17.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 2.47M | 2.69M | 2.84M | 3.04M | 5.18M |
| Operating Income | -3.41M | -5.26M | -6.03M | -9.66M | -11.54M |
| Net Income | -3.43M | -5.36M | -6.03M | -9.81M | -13.07M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 4.87M | 14.12M | 14.12M | 9.98M | 4.59M |
| Total Liabilities | 1.9M | 1.21M | 810k | 5.3M | 9.27M |
| Total Equity | 2.97M | 12.91M | 13.31M | 4.68M | -4.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -4.18M | -4.62M | -5.07M | -8.07M | -8.32M |
| Investing | -12k | -8k | -310k | -469k | -190k |
| Financing | 3.33M | 14.52M | 5.15M | -962k | 4.29M |
| Market Cap | 31.34M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 0.44 |
| Price to Cash Ratio | 10 |
| Price to Book Ratio | -0.49 |
| Dividend Yield | - |
| Shares Outstanding | 32.65M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 5.05 (99.93%) |
| Company Name | Imagion Biosystems Ltd (PK) |
| Address |
c/o- k&l gates melbourne, victoria 3000 |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
